SCHEMBL22345889

SCHEMBL22345889

CCc1ccccc1NS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
POLB P06746 3/20 0.68
TSHR P16473 1/20 0.68
GRK2 P25098 1/20 0.56
TP53 P04637 2/20 0.55
THRB P10828 1/20 0.55
MAPT P10636 4/20 0.55
HTT P42858 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
CCR2 P41597 1/20 0.49
GAA P10253 1/20 0.49
USP2 O75604 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NOD2 Q9HC29 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10272404 0.86 ALDH1A1 (0.71) ALDH1A1POLBTSHRTP53THRB
SCHEMBL9141729 0.85 ALDH1A1 (0.70) ALDH1A1POLBTSHRTP53THRB
SCHEMBL7589405 0.84 MEN1 (0.59) ALDH1A1POLBTSHRMAPTHTT
SCHEMBL15232991 0.83 THRB (0.49) ALDH1A1POLBTSHRGRK2TP53
SCHEMBL15232996 0.82 CCR2 (0.48) ALDH1A1POLBTSHRGRK2TP53
SCHEMBL31681384 0.81 ALDH1A1 (0.65) ALDH1A1POLBTSHRTP53THRB
SCHEMBL16060031 0.81 ALDH1A1 (0.64) ALDH1A1POLBTSHRTP53THRB
SCHEMBL3081594 0.80 ALDH1A1 (0.71) ALDH1A1POLBTSHRTHRBMAPT
SCHEMBL2888431 0.78 MCL1 (0.49) ALDH1A1TP53THRBMAPTHTT
SCHEMBL15145878 0.77 MEN1 (0.52) ALDH1A1POLBTP53MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3923944-A1 SPT5 INHIBITORS AND USES THEREOF Yeda Research and Development Co. Ltd (IL) 2021-12-22 EP disclosed
US-20210379060-A1 SPT5 INHIBITORS AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-12-09 US disclosed
WO-2020165907-A9 SPT5 INHIBITORS AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-06-10 WO disclosed
WO-2020165907-A1 SPT5 INHIBITORS AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2020-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210379060-A1 SPT5 INHIBITORS AND USES THEREOF SUPT16H, SPTLC1, MED25 ALDH1A1 4510/4885POLB 116/4885TSHR 3321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.